| Literature DB >> 25961041 |
S Arsic1, Lj Konstantinovic2, F Eminovic3, D Pavlovic3, M B Popovic4, V Arsic5.
Abstract
It is considered that cognitive function and attention could affect walking, motion control, and proper conduct during the walk. To determine whether there is a difference in the quality of attention and cognitive ability in stroke patients and patients without neurological damage of similar age and education and to determine whether the connection of attention and cognition affects motor skills, the sample consisted of 50 stroke patients tested with hemiparesis, involved in the process of rehabilitation, and 50 persons, randomly chosen, without neurological damage. The survey used the following tests: Trail Making (TMT A B) test for assessing the flexibility of attention; Mini-Mental State Examination (MMSE) for cognitive status; Functional Ambulation Category (FAC) test to assess the functional status and parameters of walk: speed, frequency, and length of stride; STEP test for assessing the precision of movement and balance. With stroke patients, relationship between age and performance on the MMSE test was marginally significant. The ratio of performance to TMT A B test and years does not indicate statistical significance, while statistical significance between the MMSE test performance and education exists. In stroke patients, performance on MMSE test is correlated with the frequency and length of stride walk. The quality of cognitive function and attention is associated with motor skills but differs in stroke patients and people without neurological damage of similar age. The significance of this correlation can supplement research in neurorehabilitation, improve the quality of medical rehabilitation, and contribute to efficient recovery of these patients.Entities:
Mesh:
Year: 2015 PMID: 25961041 PMCID: PMC4417558 DOI: 10.1155/2015/823136
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Descriptive statistics of estimated parameters and results of comparisons between groups.
| Parameter | Stroke patients (Group 1) | Control group (Group 2) |
|
|---|---|---|---|
|
|
| ||
| Mean ± SD or | Mean ± SD or | ||
| Age | 69.9 ± 7.71 | 67.18 ± 9.27 | 0.175 |
| Gender | 0.548 | ||
| Male | 26 (52%) | 23 (46%) | |
| Female | 24 (48%) | 27 (53%) | |
| Education (in year) | 0.126 | ||
| <4 | 6 (12%) | 10 (20%) | |
| 4–8 | 21 (42%) | 18 (36%) | |
| 8–12 | 20 (40%) | 13 (26%) | |
| >12 | 3 (6%) | 9 (18%) | |
| Marital status | <0.001 | ||
| Married | 33 (66%) | 13 (26%) | |
| Widower | 3 (6%) | 11 (22%) | |
| Divorced | 14 (28%) | 18 (36%) | |
| Single | 0 (0%) | 8 (16%) | |
| MMSE | 22.72 ± 3.33 | 26.56 ± 2.62 | <0.001 |
| TMT A | 113.32 ± 51.5 | 81.82 ± 32.1 | <0.001 |
| TMT B | 262.32 ± 74.5 | 201.98 ± 84.7 | <0.001 |
| STEP balance | <0.001 | ||
| Yes | 29 (58%) | 49 (98%) | |
| Partly | 4 (8%) | 1 (2%) | |
| No | 17 (34%) | 0 (0%) | |
| FAC | 2.62 ± 1.5 | 4.76 ± 0.43 | <0.001 |
| Frequency of gait | 58.12 ± 12.15 | 18.62 ± 2.74 | <0.001 |
| Speed of gait | 75.46 ± 23.1 | 21.58 ± 5.63 | <0.001 |
| Stride length | 23.28 ± 5.4 | 52.28 ± 8.28 | <0.001 |
| STEP number of trials | 2.14 ± 0.9 | 5.4 ± 1.3 | <0.001 |
| STEP number of successful executions | 0.92 ± 0.96 | 4.84 ± 1.5 | <0.001 |
Multiple linear regressions.
| Age | Education level | Gender | Total | ||
|---|---|---|---|---|---|
| Stroke patients (Group 1) | MMSE | 4.34% | 25.66%* | 1.43% | 31.43% |
| TMT A | 0.69% | 9.05% | 5.33% | 15.07% | |
| TMT B | 5.87% | 6.55% | 3.73% | 16.15% | |
|
| |||||
| Control group (Group 2) | MMSE | 19.60%* | 32.96%* | 2.77% | 55.33% |
| TMT A | 2.71% | 14.82%# | 5.65%# | 23.18% | |
| TMT B | 17.75%* | 35.12%* | 0.05% | 52.92% | |
* P < 0.05 is significant. # P = 0.05–0.10 is of borderline significance.
Results of comparisons of MMSE, TMT A, and TMT B scores divided by age categories.
| Age (in year) | 50–59 | 60–69 | 70–79 | 80–89 |
| Power2 | |
|---|---|---|---|---|---|---|---|
| Group 1 |
| 7 | 13 | 28 | 2 | ||
| MMSE | 25 ± 2.52 | 24 ± 2.38 | 21.75 ± 3.45 | 20 ± 4.24 | 0.02 | 83.09 | |
| TMT A | 100 ± 32.3 | 108.15 ± 47.5 | 122.2 ± 56.5 | 145 ± 70.71 | 0.58 | 17.74 | |
| TMT B | 239.57 ± 66.9 | 280.5 ± 38.87 | 256.8 ± 89.5 | 300 ± 0 | 0.32 | 18.2 | |
|
| |||||||
| Group 2 |
| 11 | 18 | 16 | 5 | ||
| MMSE | 28.73 ± 2.41 | 27.22 ± 1.86 | 25.38 ± 2.16 | 23.2 ± 1.8 | 0.00 | 99.79 | |
| TMT A | 69.64 ± 28.97 | 75.94 ± 36.41 | 90.13 ± 26.6 | 103.2 ± 28.9 | 0.02 | 46.52 | |
| TMT B | 109.82 ± 70.51 | 193.5 ± 68.81 | 250.1 ± 58.3 | 281 ± 42.49 | 0.00 | 99.48 | |
1ANOVA or Kruskal-Wallis. 2Power of statistical test (in percent).
Results of comparisons of MMSE, TMT A, and TMT B scores divided by education level categories.
| Education level (duration in year) | <4 | 4–8 | 8–12 | >12 |
| Power2 | |
|---|---|---|---|---|---|---|---|
| Group 1 |
| 6 | 21 | 20 | 3 | ||
| MMSE | 18.83 ± 4.49 | 21.7 ± 2.17 | 24.25 ± 2.5 | 27.3 ± 1.15 | 0.00 | 99.79 | |
| TMT A | 162 ± 29.77 | 123.38 ± 55.37 | 102 ± 46.2 | 71.7 ± 8.32 | 0.01 | 83.16 | |
| TMT B | 300 ± 0 | 269.3 ± 90.06 | 254.1 ± 66.6 | 193.3 ± 32.3 | 0.01 | 38.21 | |
|
| |||||||
| Group 2 |
| 10 | 18 | 13 | 9 | ||
| MMSE | 24 ± 2.11 | 25.5 ± 2.15 | 27.9 ± 1.3 | 29.6 ± 1.01 | 0.00 | 99.99 | |
| TMT A | 105.9 ± 41.9 | 246.9 ± 25.9 | 63.3 ± 24.4 | 64.3 ± 15.1 | 0.00 | 99.99 | |
| TMT B | 276.5 ± 45.1 | 246.9 ± 57.8 | 148.7 ± 55.7 | 106.2 ± 59.1 | 0.00 | 99.99 | |
1ANOVA or Kruskal-Wallis. 2Power of statistical test (in percent).
(a)
| Age | NoT1 | NoSE2 | FAC | FG3 | SG4 | SL5 | Gender | Education | |
|---|---|---|---|---|---|---|---|---|---|
| MMSE | −0.468* | 0.265# | 0.278# | 0.240# | −0.393* | −0.265# | 0.428* | 0.319* | 0.639* |
| TMT A | 0.195“ | −0.030“ | −0.138“ | 0.01“ | 0.128“ | 0.179“ | −0.274# | −0.356* | −0.420* |
| TMT B | −0.012“ | −0.078“ | −0.1017“ | 0.087“ | 0.082“ | 0.173“ | −0.169“ | −0.290* | −0.281* |
1Number of trials. 2Number of successful executions. 3Frequency of gait. 4Speed of gait. 5Stride length. * P < 0.05. #Borderline statistical significant P: 0.05–0.1. “Not statistical significant P > 0.05.
(b)
| Age | NoT1 | NoSE2 | FAC | FG3 | SG4 | SL5 | Gender | Education | |
|---|---|---|---|---|---|---|---|---|---|
| MMSE | −0.638* | 0.551* | 0.638* | 0.391* | −0.372* | −0.543* | 0.312* | 0.357* | 0.746* |
| TMT A | 0.384* | −0.357* | −0.489* | −0.274# | 0.426* | 0.516* | −0.392* | −0.391* | −0.499* |
| TMT B | 0.669* | −0.670* | −0.721* | −0.337* | 0.271# | 0.418* | −0.240# | −0.22“ | −0.753* |
1Number of trials. 2Number of successful executions. 3Frequency of gait. 4Speed of gait. 5Stride length. *Statistical significant P < 0.05. #Borderline statistical significant P: 0.05–0.1. “Not statistical significant P > 0.05.
(a)
| NoT1 | NoSE2 | FAC | FG3 | SG4 | SL5 | |
|---|---|---|---|---|---|---|
| MMSE | 0.242# | 0.259# | 0.204“ | −0.313* | −0.228“ | 0.367* |
| TMT A | −0.09“ | −0.119“ | 0.036“ | 0.08“ | 0.157“ | −0.238# |
| TMT B | −0.08“ | −0.109“ | 0.086“ | 0.088“ | 0.176“ | −0.177“ |
1Number of trials. 2Number of successful executions. 3Frequency of gait. 4Speed of gait. 5Stride length. *Statistical significant P < 0.05. #Borderline statistical significant P: 0.05–0.1. “Not statistical significant P > 0.05.
(b)
| NoT1 | NoSE2 | FAC | FG3 | SG4 | SL5 | |
|---|---|---|---|---|---|---|
| MMSE | 0.316* | 0.436* | 0.319* | −0.396* | −0.477* | 0.355* |
| TMT A | −0.191“ | −0.356* | −0.203“ | 0.418* | 0.455* | −0.40* |
| TMT B | −0.492* | −0.559* | −0.246# | 0.269# | 0.304* | −0.268# |
1Number of trials. 2Number of successful executions. 3Frequency of gait. 4Speed of gait. 5Stride length. *Statistical significant P < 0.05. #Borderline statistical significant P: 0.05–0.1. “Not statistical significant P > 0.05.